Ascensia Diabetes Care has expanded its CONTOUR product portfolio with the launch of CONTOUR COMFORT pen needles, designed to improve stability, control and ease of use during insulin injections.

Athenahealth, Aetna CVS Health and Catalyst Health Group have received the 2026 KLAS Points of Light and K2 Collaborative Peak awards for their work in improving real-time clinical data exchange between payers and providers.

Subtle Medical has received US FDA clearance for SubtleHD™(PET), its latest AI-powered PET image enhancement software designed to improve image quality and speed up PET imaging workflows across PET/CT and PET/MR systems.

Leo Cancer Care has received CE mark approval for Marie®, its upright radiotherapy system designed to change conventional cancer treatment approaches in Europe.

Trax Surgical has completed the first patient procedure using its REDIFIX suture anchor system, following recent regulatory clearance in the United States.

EmStop has announced the start of the CAPTURE-2 Investigational Device Exemption (IDE) clinical trial for its investigational embolic protection system designed for Transcatheter Aortic Valve Replacement

Cancer Check Labs has entered into a strategic partnership with Evexia Diagnostics to expand access to early cancer detection testing through the CancerCheck multi-cancer early detection (MCED) test.

Cepheid, a company of Danaher, has received CE marking under the In Vitro Diagnostic Regulation (IVDR) for its Xpert® GI Panel. The multiplex PCR test is designed to rapidly detect 11 gastrointestinal pathogens from a single patient sample.

Philips secures spot on Financial Times' top 3 medtech employers in Asia for 2026, backed by robust full-year 2025 sales of $20.62 billion and rising order intake in key hospital technologies.

Sincere Healthcare Group and Landmark Medical Centre have mutually agreed to terminate their partnership, ensuring continuity of operations in Johor Bahru.